CML HealthCare to sell itself in C$1.22 billion deal
June 25 (Reuters) - Canadian medical diagnostic services provider CML HealthCare Inc said it would be bought by LifeLabs Medical Laboratory Services in a deal valued at C$1.22 billion ($1.16 billion), including debt.
LifeLabs, owned by Ontario Municipal Employees Retirement System (OMERS), will pay C$10.75 per share, representing a 49 percent premium to CML's closing price on Monday.
The offer price includes the assumption of $255 million of debt, CML said in a statement on Tuesday.
- Malaysian plane presumed crashed; questions over false IDs |
- China draws 'red line' on North Korea, says won't allow war on peninsula
- Warning shots fired to turn monitors back from Crimea |
- Malaysian plane crashed off Vietnam coast: state media